A comprehensive international review of 54 studies concluded that the pill doesn't heighten a woman's long-term probability of getting breast cancer.
A review says that the pill won't increase the likelihood of breast cancer over the long run.
They rush the product to market, and ignore some of the conventional product development cycle steps.